Threadneedle UK Select Fund L Gross Accumulation GBP
|AstraZeneca PLC||6.49 %|
|GlaxoSmithKline PLC||5.75 %|
|Royal Dutch Shell PLC B||4.84 %|
|British American Tobacco PLC||4.65 %|
|Schroders PLC||4.33 %|
|Intermediate Capital Group PLC||4.23 %|
|BP PLC||3.94 %|
|Tesco PLC||3.79 %|
|London Stock Exchange Group PLC||3.68 %|
|St James's Place PLC||3.66 %|
|United Kingdom||100.00 %|
|Financial Services||24.38 %|
|Consumer Defensive||24.18 %|
|Communication Services||10.84 %|
|Basic materials||7.85 %|
|Consumer Cyclical||5.32 %|
Mark Westwood joined the company in 2006 as a portfolio manager in the UK equities team. He manages the Threadneedle UK Select Fund and co-manages the Threadneedle UK Absolute Alpha Fund. He also has research responsibility for the mining and other financials sectors. He started his fund management career in 1998 with Legg Mason before moving to Morley in 2005. Mark graduated with a BSc (Hons) in materials science from Manchester University. He also holds a PhD in materials science and is an associate member of the Institute of Investment Management and Research.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.